Evaluation of the Combinatory Anticancer Effect of Chemotherapeutic Compounds and Prodigiosin against HCT-116, LoVo, and A549 Cell lines

MLA

Fares Elghali, et al. “Evaluation of the Combinatory Anticancer Effect of Chemotherapeutic Compounds and Prodigiosin against HCT-116, LoVo, and A549 Cell Lines.” ACS Omega, vol. 9, no. 49, Nov. 2024, pp. 48112–24. EBSCOhost, https://doi.org/10.1021/acsomega.4c04760.

APA

Fares Elghali, Dhouha Msalbi, Fakher Frikha, Mona Alonazi, Emna Sahli, Bochra Hakim, Sami Mnif, Abir Ben Bacha, & Sami Aifa. (2024). Evaluation of the Combinatory Anticancer Effect of Chemotherapeutic Compounds and Prodigiosin against HCT-116, LoVo, and A549 Cell lines. ACS Omega, 9(49), 48112–48124. https://doi.org/10.1021/acsomega.4c04760

Chicago

Fares Elghali, Dhouha Msalbi, Fakher Frikha, Mona Alonazi, Emna Sahli, Bochra Hakim, Sami Mnif, Abir Ben Bacha, and Sami Aifa. 2024. “Evaluation of the Combinatory Anticancer Effect of Chemotherapeutic Compounds and Prodigiosin against HCT-116, LoVo, and A549 Cell Lines.” ACS Omega 9 (49): 48112–24. doi:10.1021/acsomega.4c04760.